---
document_datetime: 2025-12-02 05:35:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/kogenate-bayer.html
document_name: kogenate-bayer.html
version: success
processing_time: 0.1255654
conversion_datetime: 2025-12-24 07:48:46.553833
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Kogenate Bayer

[RSS](/en/individual-human-medicine.xml/65991)

##### Lapsed

This medicine's authorisation has lapsed

octocog alfa Medicine Human Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Kogenate Bayer](#news-on)
- [More information on Kogenate Bayer](#more-information-on-kogenate-bayer-582)
- [More information on Kogenate Bayer](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 31 December 2022, the marketing authorisation of Kogenate Bayer (octocog alfa) ceased to be valid in the European Union (EU). The cessation of validity is due to the fact that the marketing authorisation holder, Bayer AG, permanently discontinued marketing of Kogenate Bayer in the European Union (EU) in December 2019. In accordance with provisions of the sunset clause1, the marketing authorisation of a medicinal product lapses if the product had not been marketed in any EU Member States for three consecutive years.

Bayer AG confirmed that it discontinued the marketing of the product because it no longer intends to market or retain the marketing authorisation for this medicinal product. KOGENATE Bayer was granted marketing authorisation in the EU on 4 August 2000 for the treatment of haemophilia A. The marketing authorisation was initially valid for a 5-year period. It was subsequently renewed for an additional 5-year period in 2005. It was then granted unlimited validity in 2010.

The European Public Assessment Report (EPAR) for Kogenate Bayer is updated to indicate that the marketing authorisation is no longer valid.

Kogenate Bayer : EPAR - Summary for the public

English (EN) (637.91 KB - PDF)

**First published:** 12/05/2009

**Last updated:** 04/05/2018

[View](/en/documents/overview/kogenate-bayer-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-484)

български (BG) (741.72 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/bg/documents/overview/kogenate-bayer-epar-summary-public_bg.pdf)

español (ES) (638.17 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/es/documents/overview/kogenate-bayer-epar-summary-public_es.pdf)

čeština (CS) (719.83 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/cs/documents/overview/kogenate-bayer-epar-summary-public_cs.pdf)

dansk (DA) (638.04 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/da/documents/overview/kogenate-bayer-epar-summary-public_da.pdf)

Deutsch (DE) (639.63 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/de/documents/overview/kogenate-bayer-epar-summary-public_de.pdf)

eesti keel (ET) (636.77 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/et/documents/overview/kogenate-bayer-epar-summary-public_et.pdf)

ελληνικά (EL) (746.22 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/el/documents/overview/kogenate-bayer-epar-summary-public_el.pdf)

français (FR) (639.44 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/fr/documents/overview/kogenate-bayer-epar-summary-public_fr.pdf)

hrvatski (HR) (659.51 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/hr/documents/overview/kogenate-bayer-epar-summary-public_hr.pdf)

italiano (IT) (637.55 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/it/documents/overview/kogenate-bayer-epar-summary-public_it.pdf)

latviešu valoda (LV) (748.66 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/lv/documents/overview/kogenate-bayer-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (673.39 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/lt/documents/overview/kogenate-bayer-epar-summary-public_lt.pdf)

magyar (HU) (704.25 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/hu/documents/overview/kogenate-bayer-epar-summary-public_hu.pdf)

Malti (MT) (741.05 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/mt/documents/overview/kogenate-bayer-epar-summary-public_mt.pdf)

Nederlands (NL) (638.12 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/nl/documents/overview/kogenate-bayer-epar-summary-public_nl.pdf)

polski (PL) (719.09 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/pl/documents/overview/kogenate-bayer-epar-summary-public_pl.pdf)

português (PT) (638.45 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/pt/documents/overview/kogenate-bayer-epar-summary-public_pt.pdf)

română (RO) (670.28 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/ro/documents/overview/kogenate-bayer-epar-summary-public_ro.pdf)

slovenčina (SK) (720.31 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/sk/documents/overview/kogenate-bayer-epar-summary-public_sk.pdf)

slovenščina (SL) (703.65 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/sl/documents/overview/kogenate-bayer-epar-summary-public_sl.pdf)

Suomi (FI) (637.24 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/fi/documents/overview/kogenate-bayer-epar-summary-public_fi.pdf)

svenska (SV) (638.15 KB - PDF)

**First published:**

12/05/2009

**Last updated:**

04/05/2018

[View](/sv/documents/overview/kogenate-bayer-epar-summary-public_sv.pdf)

## Product information

Kogenate Bayer : EPAR - Product information

English (EN) (1.17 MB - PDF)

**First published:** 12/11/2009

**Last updated:** 04/05/2018

[View](/en/documents/product-information/kogenate-bayer-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-57)

български (BG) (2.85 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/bg/documents/product-information/kogenate-bayer-epar-product-information_bg.pdf)

español (ES) (1.18 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/es/documents/product-information/kogenate-bayer-epar-product-information_es.pdf)

čeština (CS) (2.29 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/cs/documents/product-information/kogenate-bayer-epar-product-information_cs.pdf)

dansk (DA) (1.18 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/da/documents/product-information/kogenate-bayer-epar-product-information_da.pdf)

Deutsch (DE) (1.26 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/de/documents/product-information/kogenate-bayer-epar-product-information_de.pdf)

eesti keel (ET) (1.16 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/et/documents/product-information/kogenate-bayer-epar-product-information_et.pdf)

ελληνικά (EL) (2.92 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/el/documents/product-information/kogenate-bayer-epar-product-information_el.pdf)

français (FR) (1.21 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/fr/documents/product-information/kogenate-bayer-epar-product-information_fr.pdf)

hrvatski (HR) (1.25 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/hr/documents/product-information/kogenate-bayer-epar-product-information_hr.pdf)

íslenska (IS) (1.09 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/is/documents/product-information/kogenate-bayer-epar-product-information_is.pdf)

italiano (IT) (1.23 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/it/documents/product-information/kogenate-bayer-epar-product-information_it.pdf)

latviešu valoda (LV) (2.35 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/lv/documents/product-information/kogenate-bayer-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.27 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/lt/documents/product-information/kogenate-bayer-epar-product-information_lt.pdf)

magyar (HU) (2.31 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/hu/documents/product-information/kogenate-bayer-epar-product-information_hu.pdf)

Malti (MT) (2.36 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/mt/documents/product-information/kogenate-bayer-epar-product-information_mt.pdf)

Nederlands (NL) (1.23 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/nl/documents/product-information/kogenate-bayer-epar-product-information_nl.pdf)

norsk (NO) (1.11 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/no/documents/product-information/kogenate-bayer-epar-product-information_no.pdf)

polski (PL) (2.34 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/pl/documents/product-information/kogenate-bayer-epar-product-information_pl.pdf)

português (PT) (1.21 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/pt/documents/product-information/kogenate-bayer-epar-product-information_pt.pdf)

română (RO) (1.25 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/ro/documents/product-information/kogenate-bayer-epar-product-information_ro.pdf)

slovenčina (SK) (2.27 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/sk/documents/product-information/kogenate-bayer-epar-product-information_sk.pdf)

slovenščina (SL) (2.25 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/sl/documents/product-information/kogenate-bayer-epar-product-information_sl.pdf)

Suomi (FI) (1.18 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/fi/documents/product-information/kogenate-bayer-epar-product-information_fi.pdf)

svenska (SV) (1.22 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

04/05/2018

[View](/sv/documents/product-information/kogenate-bayer-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** A31/0185 16/11/2017

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Kogenate Bayer : EPAR - All authorised presentations

English (EN) (578.86 KB - PDF)

**First published:** 21/01/2008

**Last updated:** 04/03/2016

[View](/en/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-480)

български (BG) (670.85 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/bg/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_bg.pdf)

español (ES) (578.11 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/es/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_es.pdf)

čeština (CS) (621.59 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/cs/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (577.87 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/da/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (579.76 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/de/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (597.86 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/et/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (650.81 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/el/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_el.pdf)

français (FR) (577.29 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/fr/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (588.8 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/hr/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (577.27 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/is/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_is.pdf)

italiano (IT) (578.07 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/it/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (624.29 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/lv/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (591.67 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/lt/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (619.95 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/hu/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (32 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/mt/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (579.71 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/nl/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (577.7 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/no/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_no.pdf)

polski (PL) (622.3 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/pl/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_pl.pdf)

português (PT) (577.78 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/pt/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_pt.pdf)

română (RO) (591.02 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/ro/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (621.51 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/sk/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (608.87 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/sl/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (578.02 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/fi/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (578.47 KB - PDF)

**First published:**

21/01/2008

**Last updated:**

04/03/2016

[View](/sv/documents/all-authorised-presentations/kogenate-bayer-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Kogenate Bayer Active substance octocog alfa International non-proprietary name (INN) or common name octocog alfa Therapeutic area (MeSH) Hemophilia A Anatomical therapeutic chemical (ATC) code B02BD02

### Pharmacotherapeutic group

Antihemorrhagics

### Therapeutic indication

Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor-VIII deficiency).

This preparation does not contain von Willebrand factor and is therefore not indicated in von Willebrand's disease.

## Authorisation details

EMA product number EMEA/H/C/000275 Marketing authorisation holder

Bayer AG

51368 Leverkusen Germany

Marketing authorisation issued 04/08/2000 Lapse of marketing authorisation 31/12/2022 Revision 30

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Kogenate Bayer : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (1.24 MB - PDF)

**First published:** 12/11/2009

**Last updated:** 04/05/2018

[View](/en/documents/procedural-steps-after/kogenate-bayer-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Kogenate Bayer-H-C-0275-A31-0185 : EPAR - Assessment Report - Article 31

Adopted

Reference Number: EMA/763977/2017

English (EN) (797.26 KB - PDF)

**First published:** 05/12/2017

**Last updated:** 05/12/2017

[View](/en/documents/variation-report/kogenate-bayer-h-c-0275-a31-0185-epar-assessment-report-article-31_en.pdf)

Kogenate Bayer-H-C-275-A20-150 : EPAR - Assessment Report - Article 20

Adopted

Reference Number: EMA/10430/2014

English (EN) (723.67 KB - PDF)

**First published:** 20/03/2014

**Last updated:** 20/03/2014

[View](/en/documents/variation-report/kogenate-bayer-h-c-275-a20-150-epar-assessment-report-article-20_en.pdf)

Kogenate Bayer-H-C-275-A20-150 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

English (EN) (629.74 KB - PDF)

**First published:** 20/03/2014

**Last updated:** 20/03/2014

[View](/en/documents/scientific-conclusion/kogenate-bayer-h-c-275-a20-150-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

Kogenate Bayer-H-C-275-WS-193 : EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/282360/2012

English (EN) (1.22 MB - PDF)

**First published:** 21/05/2012

**Last updated:** 21/05/2012

[View](/en/documents/variation-report/kogenate-bayer-h-c-275-ws-193-epar-assessment-report-variation_en.pdf)

Kogenate Bayer : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (648.56 KB - PDF)

**First published:** 08/09/2006

**Last updated:** 08/09/2006

[View](/en/documents/steps-after-cutoff/kogenate-bayer-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Kogenate Bayer : EPAR - Procedural steps taken before authorisation

English (EN) (665.02 KB - PDF)

**First published:** 08/09/2006

**Last updated:** 08/09/2006

[View](/en/documents/procedural-steps/kogenate-bayer-epar-procedural-steps-taken-authorisation_en.pdf)

Kogenate Bayer : EPAR - Scientific Discussion

English (EN) (791.14 KB - PDF)

**First published:** 08/09/2006

**Last updated:** 08/09/2006

[View](/en/documents/scientific-discussion/kogenate-bayer-epar-scientific-discussion_en.pdf)

#### News on Kogenate Bayer

[Factor VIII medicines: no clear and consistent evidence of difference in risk of inhibitor development between classes](/en/news/factor-viii-medicines-no-clear-consistent-evidence-difference-risk-inhibitor-development-between-classes) 15/09/2017

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 May 2016](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-10-13-may-2016) 13/05/2016

[CHMP confirms PRAC recommendations on Kogenate Bayer/Helixate NexGen](/en/news/chmp-confirms-prac-recommendations-kogenate-bayer-helixate-nexgen) 20/12/2013

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 December 2013](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-16-19-december-2013) 20/12/2013

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 December 2013](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-2-5-december-2013) 06/12/2013

[PRAC considers benefits of Kogenate Bayer/Helixate NexGen outweigh risks in previously untreated patients](/en/news/prac-considers-benefits-kogenate-bayer-helixate-nexgen-outweigh-risks-previously-untreated-patients) 06/12/2013

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 March 2013](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-4-7-march-2013) 08/03/2013

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 March 2012](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-march-2012) 16/03/2012

#### More information on Kogenate Bayer

- [Kogenate Bayer and Helixate NexGen: Article-20 procedure](/en/medicines/human/referrals/kogenate-bayer-helixate-nexgen)

Questions and answers on the outcome of extension of indication application for Kogenate Bayer and Helixate Nexgen (octocog alfa)

English (EN) (610.22 KB - PDF)

**First published:** 22/03/2012

**Last updated:** 22/03/2012

[View](/en/documents/medicine-qa/questions-and-answers-outcome-extension-indication-application-kogenate-bayer-and-helixate-nexgen-octocog-alfa_en.pdf)

#### More information on Kogenate Bayer

- [Factor VIII - referral](/en/medicines/human/referrals/factor-viii)

**This page was last updated on** 02/03/2023

## Share this page

[Back to top](#main-content)